Epidemiological and clinical aspects of human brucellosis in eastern Anatolia

J Nippon Med Sch. 2012;79(5):343-8. doi: 10.1272/jnms.79.343.

Abstract

Background: We investigated the seroprevalence of human brucellosis and risk factors in a village in Eastern Anatolia, Turkey, where a brucellosis outbreak among cattle had recently occurred.

Patients and methods: All 501 inhabitants enrolled were screened with the Rose Bengal Test and were asked to fill out a questionnaire to determine the signs and symptoms of brucellosis and the risk factors. Patients' laboratory findings and clinical responses were also evaluated.

Results: The Rose Bengal Test was positive in 44 persons. In comparison of age groups, fever (20.2%), arthralgia (19.2%) and weight loss (8.4%) were frequently seen in children (p<0.05). Hepatomegaly (17.9%) was also prevalent in the age group of 0 to 14 years (p<0.05). The consumption of dairy products, a family history of brucellosis, and raising livestock were significantly related to seropositivity (p<0.05). Rifampicin plus doxycyline was the most common regimen administered in these cases (54.5%) and also had the highest relapse rate (p<0.05).

Conclusion: Brucellosis remains an important public-health problem in the rural areas of Turkey. Appropriate public health measures and education must be pursued to eradicate human brucellosis.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Animals
  • Brucellosis / diagnosis
  • Brucellosis / drug therapy
  • Brucellosis / epidemiology*
  • Brucellosis / prevention & control
  • Brucellosis, Bovine / epidemiology
  • Cattle
  • Child
  • Child, Preschool
  • Cholestyramine Resin
  • Doxycycline / administration & dosage
  • Drug Therapy, Combination
  • Female
  • Health Education
  • Humans
  • Male
  • Middle Aged
  • Prevalence
  • Rifampin / administration & dosage
  • Risk Factors
  • Rose Bengal
  • Seroepidemiologic Studies
  • Treatment Outcome
  • Turkey / epidemiology
  • Young Adult

Substances

  • Cholestyramine Resin
  • Rose Bengal
  • Doxycycline
  • Rifampin